Beyond the Crystal Structure: Insight into the Function and Vaccine Potential of TbpA Expressed by Neisseria gonorrhoeae

Infection and Immunity
Devin R CashCynthia Nau Cornelissen

Abstract

Neisseria gonorrhoeae, the causative agent of the sexually transmitted infection gonorrhea, is not preventable by vaccination and is rapidly developing resistance to antibiotics. However, the transferrin (Tf) receptor system, composed of TbpA and TbpB, is an ideal target for novel therapeutics and vaccine development. Using a three-dimensional structure of gonococcal TbpA, we investigated two hypotheses, i.e., that loop-derived antibodies can interrupt ligand-receptor interactions in the native bacterium and that the loop 3 helix is a critical functional domain. Preliminary loop-derived antibodies, as well as optimized second-generation antibodies, demonstrated similar modest ligand-blocking effects on the gonococcal surface but different effects in Escherichia coli. Mutagenesis of loop 3 helix residues was employed, generating 11 mutants. We separately analyzed the mutants' abilities to (i) bind Tf and (ii) internalize Tf-bound iron in the absence of the coreceptor TbpB. Single residue mutations resulted in up to 60% reductions in ligand binding and up to 85% reductions in iron utilization. All strains were capable of growing on Tf as the sole iron source. Interestingly, in the presence of TbpB, only a 30% reduction in Tf-iron...Continue Reading

References

Dec 1, 1992·Journal of General Microbiology·J F Briat
Jun 1, 1991·Journal of Bacteriology·C ElkinsP F Sparling
Jan 1, 1981·Annual Review of Biochemistry·J B Neilands
Jan 31, 1998·Molecular Microbiology·C N CornelissenP F Sparling
Jul 19, 2000·Infection and Immunity·C N CornelissenP F Sparling
Dec 12, 2001·The Journal of Infectious Diseases·J E AndersonP F Sparling
Jan 18, 2002·Infection and Immunity·Heather P Masri, Cynthia Nau Cornelissen
Mar 22, 2003·Preventive Medicine·Thomas A FarleyWhitney Elkins
Jun 1, 1963·Journal of Bacteriology·D S KELLOGGD I PIRKLE
Dec 23, 2003·Infection and Immunity·Gregory A PriceCynthia Nau Cornelissen
Feb 24, 2004·Infection and Immunity·Mary Kate Yost-Daljev, Cynthia Nau Cornelissen
Nov 23, 2005·Bioinformatics·Konstantin ArnoldTorsten Schwede
Apr 18, 2007·Infection and Immunity·Amanda J DeRocco, Cynthia Nau Cornelissen
Jun 15, 2007·Infection and Immunity·Johanna K HansenKatrina T Forest
Mar 19, 2008·Infection and Immunity·Jennifer M Noto, Cynthia Nau Cornelissen
Jan 5, 2011·Emerging Infectious Diseases·Makoto OhnishiJo Kitawaki
Feb 18, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Peter T BeerninkDan M Granoff
Jul 13, 2011·Frontiers in Microbiology·Ann E JerseLotisha E Garvin
Jul 13, 2011·Frontiers in Microbiology·Cynthia Nau Cornelissen, Aimee Hollander
Aug 17, 2011·International Journal of Women's Health·Cheryl K Walker, Richard L Sweet
Feb 14, 2012·Nature·Nicholas NoinajSusan K Buchanan
Feb 22, 2012·Nature Structural & Molecular Biology·Charles CalmettesTrevor F Moraes
Sep 11, 2012·Molecular Microbiology·Nicholas NoinajCynthia Nau Cornelissen
Nov 6, 2014·The New England Journal of Medicine·Monica M LahraDavid M Whiley

❮ Previous
Next ❯

Citations

Mar 10, 2017·Critical Reviews in Biochemistry and Molecular Biology·Anastassia K Pogoutse, Trevor F Moraes
Jan 31, 2020·Frontiers in Microbiology·Ravi YadavCynthia Nau Cornelissen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Bacterial Transport Proteins

Bacterial transport proteins facilitate active and passive transport of small molecules and solutes across the bacterial membrane. Here is the latest research.

Bacterial Transport Proteins (ASM)

Bacterial transport proteins facilitate active and passive transport of small molecules and solutes across the bacterial membrane. Here is the latest research.

Bacterial Protein Structures

Bacterial protein structures can expedite the development of novel antibiotics. Here is the latest research on bacterial proteins and the resolution of their structures.

Bacterial Protein Structures (ASM)

Bacterial protein structures can expedite the development of novel antibiotics. Here is the latest research on bacterial proteins and the resolution of their structures.